Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a precision guided biotech/life sciences company focused on advancing the clinical development programs of novel and potentially ...
The phase 2b study is an open-label trial that will enroll 40 men with advanced prostate cancer who are appropriate candidates for ADT. Participants will receive an initial loading dose of teverelix ...
MedPage Today on MSN
Similar prostate cancer drugs show different results in real-world study
Better short-term survival with apalutamide versus darolutamide, but lots of unanswered qu ...
If you’re dealing with advanced prostate cancer, the thought of surgery might feel like a lot to take in — and that’s completely understandable. For many men facing an advanced diagnosis, surgery will ...
Medicus Pharma (NASDAQ:MDCX) announced that it has received “study may proceed” clearance from the US Food and Drug ...
Breakthrough for prostate cancer patients as NHS now offers life-extending drug - The new medication is suitable for patients who are unable to receive chemotherapy or standard treatments ...
From AI-generated biopsy reports to new imaging techniques, these are the latest developments in advanced prostate cancer research that your doctor may be keeping tabs on. Much of managing advanced ...
A targeted cancer drug niraparib, used in combination with hormone therapy, was found to reduce the risk of prostate tumor growth and slow symptom advance. File Photo by Billie Jean Shaw/UPI A new ...
As we gear up to observe World Cancer Day 2026 under the theme 'United by Unique', let's take a look at the stages of ...
—As more men are cured of prostate cancer, or are long-term survivors, the challenges of survivorship are in the spotlight. Improved screening practices, earlier detection, and better therapies have ...
SAN ANTONIO — A small pilot study delivered a big message about the use of testosterone in men with advanced or metastatic prostate cancer, according to a "Best Abstract" presented at the Sexual ...
Of all the health conditions facing men as they get older, there is no doubt that prostate cancer is the most widely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results